David Jaworski
FDA/CDER/OC/OMQ
Senior Policy Advisor, Office of Manufacturing Quality
David Jaworski is currently a Senior Policy Advisor in CDER’s Office of Manufacturing Quality.
David worked for Lachman Consultants for two interim years as a Director in their compliance practice. Previously at FDA, David worked in the Divisions of Domestic Drug Quality and the International Drug Quality where he was a Consumer Safety Officer, Team Leader, and Acting Branch Chief. Prior to working at the FDA, David’s 36 year career in the pharmaceutical and biotech industries spanned from working in laboratories to manufacturing. He has broad experience in all aspects of drug product manufacturing, including biotech and small molecule manufacturing, operation of plants, quality management, large project management, and P & L management. He has worked on state of the art technology development projects, and design and construction of world class pharmaceutical plants.
David received his B.S. in Microbiology from Penn State University, and MBA in Operations & Management from Syracuse University.--May 2016,
David worked for Lachman Consultants for two interim years as a Director in their compliance practice. Previously at FDA, David worked in the Divisions of Domestic Drug Quality and the International Drug Quality where he was a Consumer Safety Officer, Team Leader, and Acting Branch Chief. Prior to working at the FDA, David’s 36 year career in the pharmaceutical and biotech industries spanned from working in laboratories to manufacturing. He has broad experience in all aspects of drug product manufacturing, including biotech and small molecule manufacturing, operation of plants, quality management, large project management, and P & L management. He has worked on state of the art technology development projects, and design and construction of world class pharmaceutical plants.
David received his B.S. in Microbiology from Penn State University, and MBA in Operations & Management from Syracuse University.--May 2016,